Results 141 to 150 of about 680,918 (208)

Successful treatment with sintilimab for SMARCA4-deficient non-small cell lung carcinoma: two case reports. [PDF]

Discov Oncol
Wang L, Ke H, Wang C, Wang K.
europepmc   +1 more source

Unresectable Lung Small Cell Carcinoma [PDF]

, 2020
openaire   +1 more source

AHCYL1 mediates the tumor-promoting effect of PREX2 in non-small cell lung carcinoma. [PDF]

Theranostics
Lei M, Yeung YT, Nie W, Yang R, Li J, Chen H, Zhao R, Liu K, Dong Z.   +8 more
europepmc   +1 more source

Evaluation of TTF-1, Napsin A, p40, and p63 in the Subtyping of Non-Small Cell Lung Carcinoma: A Cross-Sectional Study from India. [PDF]

Iran J Pathol
Patel S, Anandarama Adiga DS.
europepmc   +1 more source

Refractory Lung Small Cell Carcinoma [PDF]

, 2020
openaire   +1 more source

Performance and considerations in the use of diagnostic mutation panels for clonality testing in non-small-cell lung carcinoma. [PDF]

ESMO Open
Janssen J, Andrade Barbosa B, Machado JC, Hofman P, Kim Y, Ylstra B, Radonic T.   +6 more
europepmc   +1 more source

Occult Lung Small Cell Carcinoma [PDF]

, 2020
openaire   +1 more source

Common Diseases Presenting in an Uncommon Way: Metastatic Small-Cell Lung Carcinoma Mimicking Merkel Cell Carcinoma. [PDF]

Cureus
Boican A.
europepmc   +1 more source

In Vitro and In Vivo Evaluation of Alectinib-Loaded Dendrimer Nanoparticles as a Drug Delivery System for Non-Small Cell Lung Carcinoma. [PDF]

Pharmaceutics
Atta MR, Atta MR, Al-Ani I, Aldeeb I, AlAzzam KM, Ata T, Almullah MA, Daoud E, Al-Hajji F.   +8 more
europepmc   +1 more source

Peripheral blood neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index values as prognostic predictors for non-small cell lung carcinoma. [PDF]

Am J Transl Res
Liu Q, Hu Y, Li Y, Qian H, Shi D, Ji L.
europepmc   +1 more source